GlassScriptPhysician profile
Jacy Villa
NPI 1811995434
$1,412.32
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $741 · 2020: $319 · 2021: $301 · 2023: $50.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $50.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $50.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $306.58 | 2019-2023 | Darzalex, Tecvayli |
| Astrazeneca Pharmaceuticals LP | $271.71 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $107.26 | 2019-2023 | |
| Seagen INC. | $102.00 | 2019 | |
| Astellas Pharma US INC | $91.79 | 2019-2021 | |
| Foundation Medicine, INC. | $80.89 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $65.64 | 2019-2021 | |
| Daiichi Sankyo INC. | $58.28 | 2020 | |
| Merck Sharp & Dohme LLC | $51.27 | 2019-2020 | |
| Amgen INC. | $37.49 | 2019-2020 | |
| Gilead Sciences, INC. | $32.41 | 2019 | |
| Celgene Corporation | $31.86 | 2020-2021 | |
| Helsinn Therapeutics (U.S.), INC. | $30.17 | 2019 | |
| Jazz Pharmaceuticals INC. | $24.10 | 2019 | |
| Pfizer INC. | $23.79 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Taiho Oncology, INC. | $20.18 | 2020 | |
| Exelixis INC. | $17.81 | 2019 | |
| Genentech USA, INC. | $16.72 | 2021 | |
| Verastem, INC. | $15.89 | 2019 | |
| Dova Pharmaceuticals | $13.30 | 2021 | |
| Emd Serono, INC. | $13.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacy Villa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.